Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Financial Results (Apr 28, 2026)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed April 28, 2026
Period End
April 28, 2026
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Jan ’17Jan ’17
  2. Material agreement8-K · Feb ’19Feb ’19
  3. Leadership change8-K · Aug ’21Aug ’21
  4. Material agreement8-K · Jun ’25Jun ’25

Summary

Summary of the 8-K filed April 28, 2026. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. (NYSE: OHI) reported first quarter 2026 results on April 28, 2026, with net income of $159 milliona, or $0.47 per diluted share, compared to $112 million, or $0.33 per diluted share, in Q1 2025.

Adjusted FFO was $260 millionb, or $0.82 per diluted share, on 315 million weighted-average diluted shares, versus $221 million, or $0.75 per diluted share, a year earlier. FAD was $247 million, or $0.78 per diluted share, compared to $211 million, or $0.71 per diluted share, in Q1 2025. Management stated that FAD per share rose 9.5% year over year.

The company completed $251 millionc of new investments in Q1 2026, including $126 million in real estate acquisitions, $27 million in real estate loan fundings, and $97 million in unconsolidated entity investments, the largest being a 9.9% equity interest in Saber Healthcare Holdings for $93 million. It also issued 2 million common shares for gross proceeds of $107 million and completed $75 million of additional investments in April 2026. Omega announced the expected sale of 18 CommuniCare facilities in Q2 2026 for $480 million, which management said, once redeployed, would add a further three cents to FAD.

Omega raised the low end of its 2026 Adjusted FFO guidance to a range of $3.19 to $3.25d per diluted share, from $3.15 to $3.25, moving the midpoint up by two cents to $3.22. The company had $4.5 billion of outstanding indebtedness at a weighted average interest rate of 4.2% as of March 31, 2026, and declared a quarterly dividend of $0.67 per share payable May 15, 2026. Genesis Healthcare, which is in Chapter 11, continued to make contractual rent and interest payments through April 2026, and Omega funded $25.0 million under a new DIP financing.

Key Highlights

  1. Q1 2026 net income of $159 million ($0.47 per diluted share), up from $112 million ($0.33 per diluted share) in Q1 2025.
  2. Q1 2026 Adjusted FFO of $260 million ($0.82 per diluted share), up from $221 million ($0.75 per diluted share) in Q1 2025.
  3. FAD of $247 million ($0.78 per diluted share) in Q1 2026, compared to $211 million ($0.71 per diluted share) in Q1 2025.
  4. Completed $251 million of new investments in Q1 2026 and an additional $75 million in April 2026, including a 9.9% equity interest in Saber for $93 million.
  5. Expected sale of 18 CommuniCare facilities in Q2 2026 for $480 million; 12 Maryland facilities were sold in April 2026.
  6. 2026 Adjusted FFO guidance range narrowed to $3.19 to $3.25 per diluted share, with the midpoint raised by two cents to $3.22.
  7. Quarterly dividend of $0.67 per share declared April 23, 2026, payable May 15, 2026 to holders of record on May 4, 2026.

Frequently Asked Questions

  1. How did Omega's first quarter 2026 earnings compare with the prior year?

    Net income was $159 million, or $0.47 per diluted share, versus $112 million, or $0.33 per diluted share, in Q1 2025. Adjusted FFO was $260 million, or $0.82 per diluted share, compared with $221 million, or $0.75 per diluted share. FAD was $247 million, or $0.78 per diluted share, versus $211 million, or $0.71 per diluted share.

  2. What investments did Omega make in the first quarter of 2026?

    Omega completed $251 million of investments: $126 million of real estate acquisitions (including 13 Georgia skilled nursing facilities and an Alabama senior housing facility), $27 million of real estate loan fundings, and $97 million in unconsolidated entities, primarily a 9.9% equity interest in Saber Healthcare Holdings for $92.6 million in cash consideration. Omega will receive minimum quarterly cash distributions equivalent to an 8% annualized yield on that investment.

  3. What is the status of the CommuniCare facility disposition and Genesis exposure?

    Omega held 19 facilities classified as assets held for sale at March 31, 2026, totaling $233.1 million in net book value, including 18 CommuniCare facilities. In April 2026, 12 Maryland facilities were sold, and the remaining six West Virginia facilities are expected to sell in Q2 2026 for an aggregate $479.9 million, though the filing states there is no assurance this will occur. Genesis, which filed for Chapter 11 on July 9, 2025, has made all required contractual rent and interest payments through April 2026, and Omega agreed to provide up to $26.7 million of a new $80.0 million DIP financing, with $25.0 million funded as of March 31, 2026.

  4. What is Omega's updated 2026 guidance and what assumptions underlie it?

    Omega expects 2026 Adjusted FFO of $3.19 to $3.25 per diluted share, versus the prior range of $3.15 to $3.25. Key assumptions include no additional operators placed on a cash basis, Genesis paying its full contractual rent of $13.3 million per quarter, Maplewood paying $19.5 million per quarter, quarterly G&A of approximately $14 million to $15 million, and the 18 CommuniCare facilities being sold for $480 million. The guidance excludes acquisitions and acquisition costs, capital markets activity, and provisions for credit losses.

  5. What is Omega's debt and liquidity position?

    As of March 31, 2026, Omega had $4.5 billion of outstanding indebtedness at a weighted average annual interest rate of 4.2%, consisting of $3.8 billion of senior unsecured notes, $425.0 million on its revolving credit facility, and $300.0 million on the 2028 Term Loan. It had $26.1 million of cash and cash equivalents and $1.6 billion of undrawn capacity under its unsecured revolving credit facility.